ISRCTN36459506
Active, not recruiting
未知
Molecular and genetic profile of colorectal cancer in Rwanda
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- KU Leuven
- Enrollment
- 300
- Status
- Active, not recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Histologically confirmed colorectal cancer
- •2\. Diagnosis made or reviewed at King Faisal Hospital (KFH) between 01/01/2019 and 29/02/2021, or prospectively from 21/03/2021 to 31/05/2021
Exclusion Criteria
- •Patients with colorectal masses that are not histologically confirmed
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Molecular analysis of cancers in the large intestine in patients that use statins.Colorectal carcinoma, Statins/statines, BMP, SMAD4, chemopreventionNL-OMON25857one
Recruiting
Not Applicable
Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer ProgressionColorectal CancerNCT03309722University of Southampton1,000
Unknown
Not Applicable
Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal CancerColorectal NeoplasmsNCT00220246Radboud University Medical Center130
Active, not recruiting
Not Applicable
Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer TherapyColorectal CancerColorectal Cancer MetastaticHepatic MetastasesNCT03364621University Health Network, Toronto17
Completed
Phase 2
Pharmacogenomic study on colorectal cancer chemotherapy - modified FOLFOX6- (Oxaliplatin with infusional 5-FU/l-Leucovorin) and FOLFIRI (irinotecan with infusional 5-FU/l-Leucovorin)-based regimenColorectal cancerJPRN-UMIN000006905Personalized Medicine Study Group for Cancer210